ELOX

Eloxx Pharmaceuticals Inc.

Price

$18.30

return (12m)

1,663,536.36% Logo

p/e

-0.23

p/bv

-1.19

DIVIDEND YIELD

0.00%

ELOX price

Eloxx Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ELOX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

66.21%

3 months

1,178.74%

1 year

1,663,536.36%

2 years

137.66%

5 years

-97.01%

10 years

-98.96%

Fundamentals ELOX

Valuation

P/E

-0.23

Sector -2.35

Industry 2.47

P/BV

-1.19

Sector 2.15

Industry 2.34

P/Revenue (PSR)

2.23

Sector 1.96

Industry 0.83

EV/EBITDA

-1.89

Sector -22.97

Industry -5.28

EV/EBIT

-1.89

Sector -37.52

Industry -17.09

P/EBITDA

-0.26

Sector 0.40

Industry 1.58

P/EBIT

-0.25

Sector -1.95

Industry 3.85

P/Total Assets

2.69

Sector 1.17

Industry 0.93

P/Net Current Assets

-1.19

Sector -11.01

Industry -19.51

P/Working Capital

-1.19

Sector -4.59

Industry 4.77

EPS

-62.25

Sector -0.90

Industry -0.51

BVPS

-11.91

Sector 3.82

Industry 5.86

Efficiency

Gross Margin

100.00%

Sector 44.19%

Industry 32.42%

EBITDA Margin

Sector -328.62%

Industry -72.72%

EBIT Margin

Sector -193.32%

Industry -11.24%

Operating Margin

-100.00%

Sector -24.85%

Industry -6.78%

Net Profit Margins

-100.00%

Sector -28.95%

Industry -15.92%

Asset Turnover

0.00

Sector 0.12

Industry 0.22

Profitability

ROE

522.67%

Sector -35.44%

Industry -27.29%

ROA

-1,181.21%

Sector -29.00%

Industry -14.61%

ROIC

-39.28%

Sector -441.29%

Industry -111.96%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.31

Sector 1.86

Industry 1.14

Net Debt / EBITDA

0.97

Sector -1.34

Industry -27.13

Net Debt / EBIT

0.97

Sector -0.70

Industry 3.95

Net Debt / Equity

0.40

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.16

Industry 0.51

Equity/Assets

-2.26

Sector 0.42

Industry 0.28

Liabilities/Assets

3.26

Sector 0.46

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-1.38%

Sector -

Industry -

Fundamentals ELOX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ELOX	-0.23	-1.19	522.67%	0.00%	$14.17 M	-100.00%
LLY	40.46	32.78	81.02%	0.57%	$1.02 T	34.99%
ISRG	39.74	6.82	17.15%	0.00%	$124.72 B	28.45%
SNY	6.98	1.29	18.43%	4.12%	$103.07 B	13.81%
NVS	23.36	7.11	30.41%	1.98%	$298.06 B	22.50%
TMO	30.38	4.01	13.19%	0.32%	$211.65 B	15.04%
ABT	33.60	3.57	10.61%	2.33%	$182.28 B	11.65%
MDT	22.67	2.17	9.59%	3.35%	$108.83 B	13.20%
GSK	15.96	4.51	28.24%	3.41%	$103.24 B	14.54%
CVS	45.51	1.72	3.78%	2.54%	$133.44 B	0.72%
BSX	16.43	0.00	-%	0.00%	$67.50 B	19.57%
IDXX	40.43	28.46	70.38%	0.00%	$44.28 B	24.63%
TMDX	14.97	5.21	34.80%	0.00%	$2.57 B	27.04%
RMD	19.99	4.68	23.41%	1.15%	$30.37 B	27.44%
HCA	12.92	-27.54	-213.15%	0.75%	$88.38 B	8.77%
DHR	34.39	2.62	7.61%	0.74%	$137.69 B	15.95%
SYK	37.03	5.38	14.52%	1.08%	$123.56 B	13.21%
PHG	19.28	1.89	9.80%	3.88%	$24.98 B	6.30%
COHR	104.97	4.47	4.26%	0.00%	$49.22 B	7.10%
INMD	10.92	1.44	13.18%	0.00%	$952.25 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ELOX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Eloxx Pharmaceuticals

Eloxx Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (9 people)

United States

27 years

Founded: 1999

1998

Time since IPO - 28 years

25

Employees

Eloxx Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $14.17 million, with shareholders equity totaling $-11.91 million.

The company employs approximately 25 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Eloxx Pharmaceuticals Inc. reported $6.36 million in revenue, generating net income of $-62.25 million.

Key financial metrics include a P/E ratio of -0.23, a price-to-book (P/B) ratio of -1.19, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ELOX.

Market cap

$14.17 million

Net worth

$-11.91 million

$-11,910,000.00

Assets

$5.27 million

$5,270,000.00

Total Shares Outstanding

1.00 million

1,000,000

Average Daily Trading Volume

$50.01 Thousand

$50,008.70

Sector

Health

Industry

Pharmaceutical Products

ELOX

ELOX revenue and profits

Financial Results ELOX

DRAG THE FRAME TO SEE MORE DATA

ELOX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$95.40 50,16% (12M)

P/E

45.51

2.54%

ROE

3.78%

P/BV

1.72

CI - Cigna

$279.77 4,58% (12M)

P/E

10.87

2.18%

ROE

16.04%

P/BV

1.74

CNC - Centene

$65.66 156,57% (12M)

P/E

-5.98

0.00%

ROE

-22.51%

P/BV

1.35

HUM - Humana

$381.71 45,20% (12M)

P/E

34.70

0.96%

ROE

6.63%

P/BV

2.30

SNY - Sanofi

$43.48 --4,12% (12M)

P/E

6.98

4.12%

ROE

18.43%

P/BV

1.29

HCA - HCA Healthcare

$410.59 8,30% (12M)

P/E

12.92

0.75%

ROE

-213.15%

P/BV

-27.54

LLY - Eli Lilly

$1,175.66 86,66% (12M)

P/E

40.46

0.57%

ROE

81.02%

P/BV

32.78

NVS - Novartis

$156.04 36,14% (12M)

P/E

23.36

1.98%

ROE

30.41%

P/BV

7.11